YoungMula
Long

IMUC Up 40% On Positive Feedback From European Medical Agency

AMEX:IMUC   IMMUNOCELLULAR THERAPEUTICS
29 0 0
News: Phase 3 program given thumbs up for it's lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma


http://finance.yahoo.com/news/immunocellular-therapeutics-receives-positive-regulatory-110000104.html
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out